For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.
News-Medical.Net on MSN
DNA analysis of colorectal polyps improves diagnosis and treatment
In about 5–10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.
For years, researchers have noted an alarming rise in colorectal cancer in younger people that’s not fully explained away by ...
Dr. Bethany Malone has treated a lot of colorectal cancer patients. The youngest, not counting those with genetic conditions, ...
Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP), its second indication after severe asthma. The anti-TSLP antibody has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback